glucobay 100 tablet 100 mg
bayer (south east asia) pte ltd - acarbose - tablet - 100 mg - acarbose 100 mg
glucobay 50 tablet 50 mg
bayer (south east asia) pte ltd - acarbose - tablet - 50 mg - acarbose 50 mg
advagraf prolonged release hard capsules 0.5 mg
astellas pharma singapore pte. ltd. - tacrolimus monohydrate 0.51 mg eqv anhydrous tacrolimus 0.5 mg - capsule, extended release - 0.5 mg - tacrolimus monohydrate 0.51 mg eqv anhydrous tacrolimus 0.5 mg 0.5 mg
advagraf prolonged release hard capsules 1 mg
astellas pharma singapore pte. ltd. - tacrolimus monohydrate 1.02 mg eqv anhydrous tacrolimus 1.0 mg - capsule, extended release - 1.0 mg - tacrolimus monohydrate 1.02 mg eqv anhydrous tacrolimus 1.0 mg 1.0 mg
advagraf prolonged release hard capsules 5 mg
astellas pharma singapore pte. ltd. - tacrolimus monohydrate 5.1 mg eqv anhydrous tacrolimus 5.0 mg - capsule, extended release - 5.0 mg - tacrolimus monohydrate 5.1 mg eqv anhydrous tacrolimus 5.0 mg 5.0 mg
synflorix suspension for injection (prefilled syringe)
glaxosmithkline pte ltd - conjugate of streptococcus pneumoniae type 1 & haemophilus influenzae protein d; conjugate of streptococcus pneumoniae type 14 and haemophilus influenzae protein d; conjugate of streptococcus pneumoniae type 18c and tetanus toxoid; conjugate of streptococcus pneumoniae type 19f and diphtheria toxoid; conjugate of streptococcus pneumoniae type 23f and haemophilus influenzae protein d; conjugate of streptococcus pneumoniae type 4 and haemophilus influenzae protein d; conjugate of streptococcus pneumoniae type 5 and haemophilus influenzae protein d; conjugate of streptococcus pneumoniae type 6b and haemophilus influenzae protein d; conjugate of streptococcus pneumoniae type 7f and haemophilus influenzae protein d; conjugate of streptococcus pneumoniae type 9v and haemophilus influenzae protein d; diphtheria toxoid (dt) carrier protein; polysaccharide (ps); protein-d (pd) carrier protein (derived from non-typeable haemophilus influenzae); tetanus toxoid (tt) carrier protein - injection, suspension - 1 μg ps1; 1.11-1.67 μg pd/dose - conjugate of streptococcus pneumoniae type 1 & haemophilus influenzae protein d 1 μg ps1; 1.11-1.67 μg pd/dose; conjugate of streptococcus pneumoniae type 14 and haemophilus influenzae protein d 1 μg ps14; 1.00-1.82 μg pd/dose; conjugate of streptococcus pneumoniae type 18c and tetanus toxoid 3 μg ps18c; 5.45-10.00 μg tt/dose; conjugate of streptococcus pneumoniae type 19f and diphtheria toxoid 3 μg ps19f; 3.33-6.00 μg dt/dose; conjugate of streptococcus pneumoniae type 23f and haemophilus influenzae protein d 1 μg ps23f; 0.39-0.74 μg pd/dose; conjugate of streptococcus pneumoniae type 4 and haemophilus influenzae protein d 3 μg ps4; 3.33-6.67 μg pd/dose; conjugate of streptococcus pneumoniae type 5 and haemophilus influenzae protein d 1 μg ps5; 0.67-1.25 μg pd/dose; conjugate of streptococcus pneumoniae type 6b and haemophilus influenzae protein d 1 μg ps6b; 0.56-0.95 μg pd/dose; conjugate of streptococcus pneumoniae type 7f and haemophilus influenzae protein d 1 μg ps7f; 0.87-1.43 μg pd/dose; conjugate of streptococcus pneumoniae type 9v and haemophilus influenzae protein d 1 μg ps9v; 1.00-1.82 μg pd/dose; diphtheria toxoid (dt) carrier protein 3-6 μg dt/dose (total dt content); polysaccharide (ps) 16 μg/dose (total ps content); protein-d (pd) carrier protein (derived from non-typeable haemophilus influenzae) 9-16 μg pd/dose (total pd content); tetanus toxoid (tt) carrier protein 5-10 μg/dose (total tt content)
aspirin 75mg gastro-resistant tablets caprin 75mg gastro-resistant tablets
wockhardt uk limited - acetylsalicylic acid - gastro-resistant tablet - acetylsalicylic acid 75 mg - antithrombotic agents
desflurane 100% (v/v) inhalation vapour, liquid
piramal healthcare uk limited - desflurane - inhalation vapour liquid - 100% (v/v) - nervous system; anesthetics; general; halogenated hydrocarbons - it is indicated as an inhalation agent for induction and maintenance of general anesthesia for inpatient and outpatient surgery in adults and for the maintenance of anaesthesia in infants and children.
haemoperfusion unit, absorption column
rem systems pty ltd - 34422 - haemoperfusion unit, absorption column - the cytosorb device is a non-pyrogenic, sterile, single use device designed to remove cytokines. cytosorb contains adsorbent polymer beads that adsorb cytokines as blood passes through the device. cytosorb is placed in a blood pump circuit.
adsorba kit - haemoperfusion unit
vantive pty ltd - 35104 - haemoperfusion unit - an assembly of devices that consists of an extracorporeal blood system and a container filled with adsorbent material that removes a wide range of substances, both toxic and normal, from blood flowing through it.